TAFASITAMAB-CXIX vs TALAZOPARIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TAFASITAMAB-CXIX vs TALAZOPARIB: Safety Overview
| Metric | TAFASITAMAB-CXIX | TALAZOPARIB |
|---|---|---|
| Total FAERS Reports | 736 | 1,477 |
| Deaths Reported | 108 | 278 |
| Death Rate | 14.7% | 18.8% |
| Hospitalizations | 117 | 553 |
| Average Patient Age | 68.1 yrs | 60.1 yrs |
| % Female Patients | 47.5% | 55.7% |
| FDA Approval Date | N/A | Jun 20, 2023 |
| Manufacturer | N/A | Pfizer Laboratories Div Pfizer Inc |
| Route | N/A | ORAL |
| Marketing Status | Prescription | Discontinued |